USSTOCK.TODAY
Weekend. Closed
Log in Sign up

TG Therapeutics raises 2026 annual global revenue guidance to $1 billion

The Motley Fool +1 · ·by G4L

TGTX
TGTX TG Therapeutics Inc
$64.51 -0.08%
View chart & analysis →
  1. 1TG Therapeutics raised its 2026 annual global revenue guidance to $1 billion.
  2. 2TG Therapeutics recorded a 52% year-over-year increase in U.S. BRIUMVI net product sales in the third quarter.
  3. 3TG Therapeutics achieved $233 million in U.S. net product sales in the third quarter.

So what's the key point?

TG Therapeutics has increased its expected global revenue for 2026 to $1 billion. Sales in the U.S. have grown significantly, suggesting higher future earnings.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →